Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amarin Corporation plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
AMRN
Nasdaq
2836
www.amarincorp.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amarin Corporation plc
Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater China
- May 7th, 2026 11:37 am
ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View Down
- May 7th, 2026 11:35 am
TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View
- May 7th, 2026 10:08 am
UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook
- May 7th, 2026 10:00 am
Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises
- May 6th, 2026 10:06 am
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
- May 6th, 2026 9:50 am
VRTX's Q1 Earnings Beat Estimates, New Products Aid Sales Growth
- May 5th, 2026 10:57 am
All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy
- May 5th, 2026 10:00 am
European Equities Traded in the US as American Depositary Receipts Start Week Lower
- May 4th, 2026 9:09 am
CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook Raised
- May 1st, 2026 9:15 am
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
- May 1st, 2026 9:10 am
Amarin's Q1 Loss Narrower Than Expected, Sales Increase Y/Y
- Apr 30th, 2026 11:03 am
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
- Apr 30th, 2026 9:06 am
Amarin Corp PLC (AMRN) Q1 2026 Earnings Call Highlights: Revenue Growth and Market Expansion ...
- Apr 30th, 2026 1:05 am
Amarin Q1 Earnings Call Highlights
- Apr 29th, 2026 8:20 am
Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy
- Apr 29th, 2026 8:19 am
Amarin Reports 2026 First Quarter Financial Results
- Apr 29th, 2026 5:00 am
How The Amarin (AMRN) Story Is Shifting With An Unchanged US$12 Fair Value
- Apr 25th, 2026 12:03 pm
European Equities Traded in US as ADRs Ease in Thursday Trading
- Apr 23rd, 2026 9:04 am
Has Amarin (AMRN) Outpaced Other Medical Stocks This Year?
- Apr 23rd, 2026 7:40 am
Scroll